ATR (AptarGroup, Inc.) Stock Analysis - Insider Trades

AptarGroup, Inc. (ATR) is a publicly traded Healthcare sector company. As of May 21, 2026, ATR trades at $115.24 with a market cap of $7.39B and a P/E ratio of 19.45. ATR moved +1.27% today. Year to date, ATR is -6.29%; over the trailing twelve months it is -27.29%. Its 52-week range spans $103.23 to $178.03. Analyst consensus is buy with an average price target of $145.80. Rallies surfaces ATR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ATR stock inside the company?

Recent ATR insider activity includes Hudson Irene Elizabeth sold 422 and Hudson Irene Elizabeth sold 842. Rallies tracks insider transaction dates, shares, prices, and estimated values.

ATR Key Metrics

Key financial metrics for ATR
MetricValue
Price$115.24
Market Cap$7.39B
P/E Ratio19.45
EPS$5.91
Dividend Yield0.48%
52-Week High$178.03
52-Week Low$103.23
Volume185
Avg Volume0
Revenue (TTM)$3.87B
Net Income$386.60M
Gross Margin0.00%

Recent ATR Insider Trades

  • Hudson Irene Elizabeth sold 422 (~$52.07K) on May 7, 2026.
  • Hudson Irene Elizabeth sold 842 (~$103.95K) on May 7, 2026.

Latest ATR News

ATR Analyst Consensus

5 analysts cover ATR: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $145.80.

Common questions about ATR

Who is trading ATR stock inside the company?
Recent ATR insider activity includes Hudson Irene Elizabeth sold 422 and Hudson Irene Elizabeth sold 842. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ATR?
Yes. Rallies tracks ATR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ATR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ATR. It does not provide personalized investment advice.
ATR

ATR